Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Nicholson

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Vascular Medicine (London, England)|January 1, 1996
Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug developmentC D Nicholson
Psychopharmacology|January 1, 1990
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementiaC D Nicholson
Biochemical Society Transactions|February 1, 1989
Nootropics and metabolically active compounds in Alzheimer's diseaseC D Nicholson
Agents and Actions. Supplements|January 1, 1993
Cyclic nucleotide phosphodiesterase isoenzymes and asthma--outstanding issuesC D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1990
Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipramM Shahid, C D Nicholson
Journal of Autonomic Pharmacology|June 1, 1989
8-phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesteraseC D Nicholson, R Wilke
Pulmonary Pharmacology|February 1, 1994
Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthmaC D Nicholson, M Shahid
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1995
The analysis and assay of cyclic nucleotide phosphodiesterase isoenzyme activityM Shahid, C D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1988
Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial diseaseD Angerbach, C D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1987
The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensionsJ J Jukna, C D Nicholson
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Vascular Medicine (London, England)|January 1, 1996
Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug developmentC D Nicholson
Psychopharmacology|January 1, 1990
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementiaC D Nicholson
Biochemical Society Transactions|February 1, 1989
Nootropics and metabolically active compounds in Alzheimer's diseaseC D Nicholson
Agents and Actions. Supplements|January 1, 1993
Cyclic nucleotide phosphodiesterase isoenzymes and asthma--outstanding issuesC D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 1, 1990
Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipramM Shahid, C D Nicholson
Journal of Autonomic Pharmacology|June 1, 1989
8-phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesteraseC D Nicholson, R Wilke
Pulmonary Pharmacology|February 1, 1994
Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthmaC D Nicholson, M Shahid
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1995
The analysis and assay of cyclic nucleotide phosphodiesterase isoenzyme activityM Shahid, C D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1988
Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial diseaseD Angerbach, C D Nicholson
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1987
The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensionsJ J Jukna, C D Nicholson
Pageof 4